Literature DB >> 21308233

[Adhesion to leprosy treatment: inherent difficulties of the patients].

Izaildo Tavares Luna1, Eveline Pinheiro Beserra, Maria Dalva Santos Alves, Patrícia Neyva da Costa Pinheiro.   

Abstract

This research, carried in Guaiúba, Ceará, Brazil aimed to identify the difficulties for the treatment compliance of leprosy patients, relating the associated factors. This is a qualitative study; data was collected from a home visit in January 2009 using an interview guideline containing seven guiding questions. Diagnosed leprosy patients with history of non compliance to treatment participated of the study. It was used Roper, Logan and Tierney's Model of Life Activities. The speeches of the subjects were classified according to twelve life activities. The model utilization made possible a holistic approach on the barriers lived by leprosy patients in the compliance to drug treatment, in order to know the life activities of these patients to a possible adaptation of the actions addressed to this clientele.

Entities:  

Mesh:

Year:  2010        PMID: 21308233     DOI: 10.1590/s0034-71672010000600018

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  2 in total

1.  Leprosy treatment dropout: a systematic review.

Authors:  Régio José Santiago Girão; Nara Lívia Rezende Soares; Juliana Viana Pinheiro; Giuliano da Paz Oliveira; Sionara Melo Figueiredo de Carvalho; Luiz Carlos de Abreu; Vitor E Valenti; Fernando Luiz Affonso Fonseca
Journal:  Int Arch Med       Date:  2013-08-30

2.  The interference of polypharmacy and the importance of clinical pharmacy advice in the treatment of leprosy: a case-control study.

Authors:  Selma Regina Penha Silva Cerqueira; Lais Sevilha Dos Santos; Elaine Faria Morelo; Agenor de Castro Moreira Dos Santos Júnior; Carlos Augusto Felipe de Sousa; Renata Trindade Gonçalves; Gunter Hans Neto; Daniel da Silva Marques; Raimunda Nonata Ribeiro Sampaio; Patrícia Shu Kurizky; Ciro Martins Gomes
Journal:  Rev Soc Bras Med Trop       Date:  2020-06-01       Impact factor: 1.581

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.